Receive Breaking News updates as they occur
The co-pilot believed to have deliberately crashed a Germanwings plane was treated for suicidal tendencies "several years ago", before he received his pilot's licence, German prosecutors said Monday. "In the ensuing years and up until recently, he had doctors' visits and was written off sick but showed no sign of suicidal tendencies or aggression towards others," said Ralf Herrenbrueck, spokesman for the prosecutor's office in the western city of Duesseldorf. He said in a statement that prosecutors would "not take part in speculation about the deceased co-pilot's motives". Herrenbrueck said based on the evaluation of medical documents and the testimony of people who knew the co-pilot, Andreas Lubitz, there was still no indication that he had told anyone of his plans or left behind a suicide note.
UnitedHealth Group said Monday it will acquire smaller rival Catamaran for $12.8 billion, in a move they said would give them more pricing power in the pharmacy benefits business. UnitedHealth will combine Catamaran with its own pharmacy benefit manager (PBM) OptumRx, which would propel the combined company to third place in the industry behind Express Scripts and CVS Caremark. "This combination is expected to create a dynamic competitor in the PBM market by combining the strengths of Catamaran's industry-leading technology platform with the data and analytics capabilities of Optum," the two said in a statement. UnitedHealth will pay $61.50 per share for Catamaran, a 27.3 percent premium over Catamaran's closing price Friday.